The Online Investor
ICLR Buyback image

ICON Plc Buyback

OLI recorded this information on 9/19/2014

Company: ICON Plc
Buyback: ICLR buyback
$Amount Authorized: $100,000,000
Buyback Details: ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40 million buyback of the Company's ordinary shares through open market acquisitions at an average price of $49.87. In addition, the Company announced a further program under which the Company can acquire (by way of redemption) up to an additional $100 million of its outstanding ordinary shares through open market share acquisitions.

Icon is a clinical research organization. Co. operates as one business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. Co. provides a range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. engages in the development, management and analysis of programs that support various stages of the clinical development process. Co. provides services including clinical trial management, consulting, contract staffing and laboratory services.
Open the ICLR Page at The Online Investor »

Company Name: 
Icon Plc
Stock buyback: 
ICLR buyback
Website: 
www.iconplc.com
Sector: 
Biotechnology
Number of ETFs Holding ICLR: 
5
Total Market Value Held by ETFs: 
$10.55M
Total Market Capitalization: 
$11.91B
% of Market Cap. Held by ETFs: 
0.09%
 

Open the ICLR Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.17 out of 4)
35th percentile
(ranked lower than approx. 65% of all stocks covered)

Analysts' Target Price:
ICLR Stock Forecast

Based on Zacks ABR data;
powered by Xignite

ICLR Buyback Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.